Stay Updated with Latest Insights

Request for Proposals (RFP) COLLABORATE Grant Program:
Supporting Ageing Adults Living with Rare Diseases

Pfizer and the CanAge are collaborating to offer a new grant opportunity seeking grant proposals for programs that seek to explore innovative approaches to persistent challenges impacting older adults living with rare diseases. Grants will be awarded in support of organizations/institutions working to improve programs and policies focused on improving the care of adults living with rare disease.
 
CanAge will select an Expert Review Panel (ERP) to make final grant decisions, create a community of practice for the selected grantees, and share existing knowledge and tools. Organizations are invited to submit an application addressing the gaps as outlined in the RFP.
 
For all independent grants, the grant requester (and ultimately the grantee) is responsible for the design, implementation, and conduct of the independent initiative supported by the grant. Pfizer must not be involved in any aspect of project development, nor the conduct or monitoring of the indpendent program. 
 
Date RFP Issued: October 24, 2025
Geographic Scope: Global
Clinical Area: Rare Disease
Application Due Date: November 24, 2025
 
Specific Area of Interest: It is our intent to support projects that accelerate policy changes in adequate access to care and treatment for older adults living with rare diseases. Proposed projects must address one or more of the following categories:

• Assessment & Analysis: Improve and sustain care for ageing adults with rare diseases by gathering evidence to support advocacy for closing healthcare gaps and driving policy change. This can include programs that evaluate community outreach models. Application should include a thorough plan on how the evaluation data will be utilized to shape public policy.

• Education & Awareness: Supporting the development of a National Action Plan on Rare Diseases. Increase education and awareness programs for healthcare providers, patients and caregivers, including the distinction between ageing and illness. Development of resources and tools to support aging adults with rare diseases.

• Policy & Advocacy: Empower communities to advocate for better access to care through the pursuit of legislation or regulations that support ageing with RD in Patient Rights Policy frameworks, policy outreach/grassroots events, and strengthening of advocacy skill sets by connecting organizations.

Scroll to Top